Idiopathic overactive bladder (OAB) is a common condition in the United States, with a prevalence of 16% for men and 16.9% for women (World J Urol. 2003;20:327-336). OAB is costly, with related ...

Treatment with vibegron reduced the average number of micturition episodes per day and the average number of daily urgency episodes compared with placebo. The Food and Drug Administration (FDA) has ...

Urinary incontinence may be defined as urgency, stress, overflow, functional, or mixed (defined as a combination of urgency and stress urinary incontinence). Urgency incontinence associated with OAB ...

Urovant Sciences, Inc., and Holly Robinson Peete Collaborate to Bring Awareness to Overactive Bladder (OAB) Symptoms and Management Options as Part of the Time To Go™ Campaign Holly Robinson Peete ...

Overactive bladder is a long-term condition that won’t go away on its own and may worsen if a person does not get treatment. The condition can be caused by issues in how the brain and bladder ...

Experiencing an overactive bladder (OAB) is common after undergoing prostate surgery. Various treatment options exist to help manage the condition and reduce the frequent urge to urinate. OAB refers ...

Behavior modification and pharmacotherapy are the mainstays of treatment for OAB. [1] Of the agents currently available, antimuscarinics are the most commonly prescribed. Within this class of drugs, ...

Urovant Sciences announces its partnership with actress and overactive bladder (OAB) patient Holly Robinson Peete as part of its Time To Go™ campaign – an educational program to raise awareness of OAB ...